ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Alaunos Therapeutics Inc

Alaunos Therapeutics Inc (TCRT)

1,48
-0,02
(-1,33%)
Beim Schlusskurs: 13 März 9:00PM
1,48
0,00
( 0,00% )
Nach Börsenschluss: 10:16PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
1,48
Gebot
1,38
Fragen
1,49
Volumen
11.906
1,46 Tagesbereich 1,50
1,46 52-Wochen-Bereich 20,30
Marktkapitalisierung
Handelsende
1,50
Handelsbeginn
1,50
Letzte Trade
2
@
1.4881
Letzter Handelszeitpunkt
23:08:24
Finanzvolumen
US$ 17.688
VWAP
1,4856
Durchschnittliches Volumen (3 Mio.)
16.497
Ausgegebene Aktien
1.601.252
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,07
Gewinn pro Aktie (EPS)
-21,95
Erlöse
303k
Nettogewinn
-35,14M

Über Alaunos Therapeutics Inc

Ziopharm Oncology Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Ziopharm Oncology Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SE... Ziopharm Oncology Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Ziopharm Oncology Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Ziopharm Oncology Inc. ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Spec Outpatient Facility,nec
Hauptsitz
Wilmington, Delaware, USA
Gegründet
2016
Alaunos Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TCRT. The last closing price for Alaunos Therapeutics was US$1,50. Over the last year, Alaunos Therapeutics shares have traded in a share price range of US$ 1,46 to US$ 20,30.

Alaunos Therapeutics currently has 1.601.252 shares in issue. The market capitalisation of Alaunos Therapeutics is US$2,40 million. Alaunos Therapeutics has a price to earnings ratio (PE ratio) of -0.07.

TCRT Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-3.267973856211.531.651.46133211.57288861CS
4-0.21-12.4260355031.691.74171.4697911.58124402CS
12-0.62-29.52380952382.12.251.46164971.83736045CS
26-0.9-37.81512605042.384.181.46210092.32901158CS
52-14.92-90.975609756116.420.31.46311407.81045802CS
156-106.52-98.6296296296108601.51.461748900108.33308237CS
260-128.42-98.8606620477129.9601.51.461757847109.39353116CS

TCRT - Frequently Asked Questions (FAQ)

What is the current Alaunos Therapeutics share price?
The current share price of Alaunos Therapeutics is US$ 1,48
How many Alaunos Therapeutics shares are in issue?
Alaunos Therapeutics has 1.601.252 shares in issue
What is the market cap of Alaunos Therapeutics?
The market capitalisation of Alaunos Therapeutics is USD 2,4M
What is the 1 year trading range for Alaunos Therapeutics share price?
Alaunos Therapeutics has traded in the range of US$ 1,46 to US$ 20,30 during the past year
What is the PE ratio of Alaunos Therapeutics?
The price to earnings ratio of Alaunos Therapeutics is -0,07
What is the cash to sales ratio of Alaunos Therapeutics?
The cash to sales ratio of Alaunos Therapeutics is 7,82
What is the reporting currency for Alaunos Therapeutics?
Alaunos Therapeutics reports financial results in USD
What is the latest annual turnover for Alaunos Therapeutics?
The latest annual turnover of Alaunos Therapeutics is USD 303k
What is the latest annual profit for Alaunos Therapeutics?
The latest annual profit of Alaunos Therapeutics is USD -35,14M
What is the registered address of Alaunos Therapeutics?
The registered address for Alaunos Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Alaunos Therapeutics website address?
The website address for Alaunos Therapeutics is www.ziopharm.com
Which industry sector does Alaunos Therapeutics operate in?
Alaunos Therapeutics operates in the SPEC OUTPATIENT FACILITY,NEC sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 28,75
(110,47%)
31,16k
MRMMEDIROM Healthcare Technologies Inc
US$ 1,10
(77,42%)
3,76M
AAOIApplied Optoelectronics Inc
US$ 26,30
(65,72%)
2,21M
BTOGBit Origin Ltd
US$ 0,3714
(36,09%)
2,7M
PRPLPurple Innovation Inc
US$ 0,83
(25,09%)
3,47M
MKDWMKDWELL Tech Inc
US$ 0,3214
(-21,15%)
4,13k
NAYANAYA Biosciences Inc
US$ 0,255
(-20,59%)
102,29k
LGCBLinkage Global Inc
US$ 0,1831
(-19,83%)
5,8M
RGCRegencell Bioscience Holdings Ltd
US$ 11,30
(-19,80%)
1,81M
HMRHeidmar Maritime Holdings Corporation
US$ 3,46
(-15,20%)
1,54M
ICONIcon Energy Corporation
US$ 0,126
(-7,35%)
9,7M
LGCBLinkage Global Inc
US$ 0,1831
(-19,83%)
5,8M
ADTXAditxt Inc
US$ 0,0329
(-1,50%)
5,01M
DGLYDigital Ally Inc
US$ 0,083
(4,53%)
4,26M
HEPAHepion Pharmaceuticals Inc
US$ 0,0368
(-2,65%)
3,89M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen